Related Experiment Video
Updated: Feb 26, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
Atropine Treatment for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis
Giuseppe Lauriti1,2, Valentina Cascini1, Pierluigi Lelli Chiesa1
1Department of Pediatric Surgery, "Spirito Santo" Hospital and "G. d'Annunzio" University, Chieti-Pescara, Italy.
Insights
Atropine is less effective than pyloromyotomy for treating infantile hypertrophic pyloric stenosis (HPS). Current evidence does not support atropine therapy for HPS, reserving it for specific surgical candidates.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Pharmacology
Background:
- Hypertrophic pyloric stenosis (HPS) is a common infant condition.
- Atropine has been proposed as a non-surgical alternative to pyloromyotomy for HPS.
- Evidence on atropine's efficacy and safety in HPS treatment is limited.
Purpose of the Study:
- To review the efficacy of atropine in treating HPS.
- To compare atropine therapy with surgical pyloromyotomy.
Main Methods:
- Systematic review and meta-analysis of published studies.
- Searched PubMed, MEDLINE, OVID, Embase, and Cochrane databases.
- Excluded case reports and opinion articles; analyzed 51 full-text articles (508 infants).
Main Results:
- Atropine successfully treated HPS in 79.1% of infants (402/508).
- Reported atropine side effects in 15.1% of infants included tachycardia and flushed skin.
- Meta-analysis showed pyloromyotomy had a higher success rate (100% vs. 80.8%) and shorter hospital stay (5.6 vs. 10.3 days) compared to atropine.
Conclusions:
- Comparative studies suggest atropine is less effective than pyloromyotomy for HPS.
- There is a lack of high-quality evidence supporting atropine for HPS.
- Atropine should be reserved for infants unsuitable for anesthesia or surgery.
Introduction:
Several authors have reported the use of atropine as an alternative treatment to pyloromyotomy in infants with hypertrophic pyloric stenosis (HPS). Our aims were to review the efficacy of atropine in treating HPS and to compare atropine therapy versus pyloromyotomy.
Materials And Methods:
Using a defined search strategy (PubMed, MEDLINE, OVID, Embase, Cochrane databases), two investigators independently identified studies reporting the use of atropine for HPS. Case reports and opinion articles were excluded. Outcome measures included success rate, side effects, and length of hospital stay. Maneuvers were compared using Fisher's exact test, and meta-analysis was conducted using RevMan 5.3. Data are expressed as mean ± standard deviation.
Results:
Systematic review: of 2,524 abstracts screened, 51 full-text articles were analyzed. There were no prospective or randomized studies. Twelve articles (508 infants) reported HPS resolution using atropine in 402 (79.1%) patients. Atropine side effects were documented in 38/251 (15.1%) infants and included tachycardia, increased transaminases, and flushed skin. Meta-analysis: five studies compared atropine treatment (293 infants) with pyloromyotomy (537 infants). Pyloromyotomy had higher success rate (100%) than atropine (80.8%; p < 0.01) and shorter hospital stay (5.6 ± 2.3 vs. 10.3 ± 3.8 days, respectively; p < 0.0001).
Conclusion:
Comparative but nonrandomized studies indicate that atropine is less effective than pyloromyotomy to treat infants with HPS. Currently, there is no evidence-based literature to support atropine treatment in these infants. To our knowledge, atropine should be reserved for patients unfit for general anesthesia or surgery.
Related Concept Videos
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Mitral Stenosis III: Medical Management
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Direct-Acting Cholinergic Agonists: Therapeutic Uses

